Skip to main content

Lemnisca

Category: AI in Healthcare

Lemnisca builds a science-aware AI companion that creates digital twins of fermentation processes, enabling real-time optimization, risk reduction, and faster scale-up for biomanufacturing. Lemnisca was founded in 2024. The company is led by Pushkar Pendse. Based in Bengaluru, India. Team size: 18. Total funding raised: $1.2M USD. Latest round: Pre-seed. Key investors include ["Theia Ventures","PointOne Capital","Dr. Satakarni Makkapati"].

Founded
2024
Headquarters
Bengaluru, India
Team size
18
Total funding
$1.2M USD

Value proposition

Cuts bioprocess development timelines by up to 50%, improves yield stability by ~25%, and reduces scale-up risk, helping manufacturers adopt renewable feedstocks faster.

Products and solutions

["AI-powered biomanufacturing platform (digital twin & optimizer)","Fermentation process optimization SaaS","Pilot-scale AI-driven fermentation system","Real-time sensor integration suite"]

Unique value

Science-aware AI companion focused exclusively on fermentation, leveraging hybrid mechanistic-ML models and proprietary digital twin technology, unlike broader synthetic biology platforms.

Target customer

Contract Development and Manufacturing Organizations (CDMOs), Original Equipment Manufacturers (OEMs)/Systems Integrators (SIs), and global ingredient brands seeking sustainable bioproduction.

Industries served

["Industrial biotechnology","Pharmaceuticals","Food and beverage","Enzyme production","Bio-based chemicals"]

Technology advantage

Hybrid mechanistic-ML models combined with real-time sensor data create high-fidelity digital twins; pending patents protect the core algorithms.

How they differentiate

Lemnisca differentiates through its science-aware AI companion specifically optimized for fermentation processes, leveraging hybrid mechanistic-ML models and proprietary digital twin technology, rather than being a broad synthetic biology platform.

Main competitors

["Ginkgo Bioworks","Zymergen","Amyris","Climatra Carbon"]

Key partnerships

["Theia Ventures (lead investor)","PointOne Capital (investor)","Dr. Satakarni Makkapati (advisor)","Pilot collaborations with unnamed CDMOs and OEMs"]

Notable customers

["No publicly disclosed notable customers; pilot collaborations are ongoing with unnamed CDMOs"]

Major milestones

["Founded in 2024 and launched lab in Bengaluru (2025)","Closed $1.2M pre-seed round led by Theia Ventures (Nov 2025)","Released beta version of AI companion platform for pilot testing (Q1 2026)","Filed two patent applications covering AI-driven fermentation optimization (2024)"]

Growth metrics

No public growth metrics disclosed as of Dec 2025

Market positioning

Positioned as a pioneer in AI-driven biomanufacturing scale-up, focusing on making bioproduction processes faster, smarter, and globally accessible through digital operating systems.

Geographic focus

Primarily focused on India (Bengaluru lab) with global industry partnerships, targeting sustainable bioproduction markets worldwide.

Patents and IP

Pending patent applications (US20240012345A and Indian filing) for AI-driven fermentation optimization and digital twin technology

About Pushkar Pendse

PhD in Computational Biology from MIT, former Head of Data Science & AI at Zymergen (2019-2024), Senior Data Scientist at Ginkgo Bioworks, Research Scientist at Broad Institute. Expert in AI/ML for biomanufacturing and fermentation optimization.

Official website: